NORMAL SITUATION

SOCIETE BEYNOISE DE PHARMACIE

Company — Normal situation.

Financial year 2023 · Closed on 31/12/2023

Net result73,1 k €+11,8 %over 1 year
Revenue80,4 k €-3,6 %over 1 year
Equity2,4 M €+3,2 %over 1 year

Identity

Source · BCE/KBO

SOCIETE BEYNOISE DE PHARMACIE is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0459.092.882
Legal form
Private limited company
Contributed capital
18 750,00 €
Latest accounts
31/12/2023
Joint committees (1)
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 27 filings

Trend over 18 financial years

20232022202120202019
Income statement
Revenue80,4 k €83,3 k €–––
EBITDA77,4 k €86,3 k €135,4 k €314,8 k €352,4 k €
Operating result59 k €67,2 k €122 k €295,6 k €327,3 k €
Net result73,1 k €65,4 k €76,4 k €221,9 k €229,7 k €
Balance sheet
Equity2,4 M €2,3 M €2,2 M €2,1 M €1,9 M €
Total assets2,4 M €2,3 M €2,3 M €2,5 M €2,2 M €
Cash538,4 €367,2 €1,2 k €1,6 M €1,5 M €
Debts20,8 k €13,9 k €63 k €255,6 k €241,7 k €
Other
Workforce––5,1 ETP6,1 ETP5,4 ETP

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 4 ended

Active mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 novembre 2021 · 0402.307.894

Represented by HELENE GORRIA

Active

Ended mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 novembre 2021 · 0402.307.894

Represented by Marc BREYER

Ended
Alexis LECHANTEUR

Director · until 31 octobre 2021

Ended
Alexis LECHANTEUR

Director

Ended
Alexis LECHANTEUR

Manager

Ended

Full financial information

Source · NBB
202320222021202020192018
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202301/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202331/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/05/202425/04/202304/05/202216/06/202124/06/202018/06/2019
General meeting29/04/202424/04/202325/04/202203/06/202125/05/202017/06/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 27 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202329/04/202414/05/2024FrenchPDF
Abridged model31/12/202224/04/202325/04/2023FrenchPDF
Abridged model31/12/202125/04/202204/05/2022FrenchPDF
Abridged model31/12/202003/06/202116/06/2021FrenchPDF
Abridged model31/12/201925/05/202024/06/2020FrenchPDF
Abridged model31/12/201817/06/201918/06/2019FrenchPDF
Abridged model31/12/201718/06/201805/07/2018FrenchPDF
Abridged model31/12/201630/06/201728/07/2017FrenchPDF
Abridged model31/12/201530/06/201605/08/2016FrenchPDF
Abridged model31/12/201430/06/201528/07/2015FrenchPDF
Abridged model31/12/201327/06/201428/07/2014FrenchPDF
Abridged model31/12/201229/06/201325/07/2013FrenchPDF
Abridged model31/12/201116/08/201228/08/2012FrenchPDF
Abridged model31/12/201029/06/201119/07/2011FrenchPDF
Abridged model31/12/200930/06/201029/07/2010FrenchPDF
Abridged model31/12/200830/06/200929/07/2009FrenchPDF
Abridged model31/12/200718/07/200825/08/2008FrenchPDF
Abridged model31/12/200618/06/200730/07/2007FrenchPDF
Abridged model31/12/200526/06/200618/07/2006FrenchPDF
Abridged model31/12/200423/05/200515/06/2005FrenchPDF
Abridged model31/12/200311/05/200411/06/2004FrenchPDF
Abridged model31/12/200209/07/200314/07/2003FrenchPDF
Abridged model31/12/200126/06/200214/08/2002FrenchPDF
Abridged model31/12/200014/06/200111/07/2001FrenchPDF

View all 27 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

1 active · 4 ended

Active mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 novembre 2021 · 0402.307.894

Represented by HELENE GORRIA

Active

Ended mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 novembre 2021 · 0402.307.894

Represented by Marc BREYER

Ended
Alexis LECHANTEUR

Director · until 31 octobre 2021

Ended
Alexis LECHANTEUR

Director

Ended
Alexis LECHANTEUR

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution23/07/2024
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Restructuring27/05/2024
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates31/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/11/2021
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Mandates23/04/2007
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/11/2006
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 202373,1 k €↑
  2. 2022
    Annual accounts 202265,4 k €↓
  3. 2022
    Name changeSOCIETE BEYNOISE DE PHARMACIE
  4. 2021
    Annual accounts 202176,4 k €↓
  5. 2021
    Name changeSOBEPHAR
  6. 2020
    Annual accounts 2020221,9 k €↓
  7. 2019
    Annual accounts 2019229,7 k €↑
  8. 2018
    Annual accounts 2018179,9 k €↑
  9. 2017
    Annual accounts 2017165,4 k €↑
  10. 2016
    Annual accounts 2016145,7 k €↓
  11. 2015
    Annual accounts 2015155,2 k €↓
  12. 2014
    Annual accounts 2014161 k €↑
  13. 2013
    Annual accounts 2013151 k €↑
  14. 2012
    Annual accounts 2012130,5 k €↑
  15. 2011
    Annual accounts 2011111,9 k €↓
  16. 2010
    Annual accounts 2010134,6 k €↑
  17. 2009
    Annual accounts 2009120,9 k €↑
  18. 2008
    Annual accounts 2008115,9 k €↑
  19. 2007
    Annual accounts 200785,9 k €↑
  20. 2006
    Annual accounts 200637,1 k €